X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ABBOTT INDIA ELDER PHARMA/
ABBOTT INDIA
 
P/E (TTM) x -0.2 32.4 - View Chart
P/BV x 0.1 8.1 1.2% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 ELDER PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ABBOTT INDIA
Mar-16
ELDER PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3806,015 6.3%   
Low Rs1883,707 5.1%   
Sales per share (Unadj.) Rs491.21,236.9 39.7%  
Earnings per share (Unadj.) Rs-3.2122.2 -2.6%  
Cash flow per share (Unadj.) Rs14.4129.0 11.2%  
Dividends per share (Unadj.) Rs035.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs376.5521.2 72.2%  
Shares outstanding (eoy) m20.5421.25 96.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.63.9 14.7%   
Avg P/E ratio x-89.339.8 -224.4%  
P/CF ratio (eoy) x19.737.7 52.3%  
Price / Book Value ratio x0.89.3 8.1%  
Dividend payout %028.6 0.0%   
Avg Mkt Cap Rs m5,833103,296 5.6%   
No. of employees `000NA3.0 0.0%   
Total wages/salary Rs m2,1793,370 64.7%   
Avg. sales/employee Rs ThNM8,891.8-  
Avg. wages/employee Rs ThNM1,140.0-  
Avg. net profit/employee Rs ThNM878.3-  
INCOME DATA
Net Sales Rs m10,08926,284 38.4%  
Other income Rs m257504 50.9%   
Total revenues Rs m10,34626,789 38.6%   
Gross profit Rs m-7923,665 -21.6%  
Depreciation Rs m361144 250.2%   
Interest Rs m2,7568 34,028.4%   
Profit before tax Rs m-3,6534,017 -90.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1251,421 8.8%   
Profit after tax Rs m-652,596 -2.5%  
Gross profit margin %-7.813.9 -56.3%  
Effective tax rate %-3.435.4 -9.7%   
Net profit margin %-0.69.9 -6.6%  
BALANCE SHEET DATA
Current assets Rs m9,24014,446 64.0%   
Current liabilities Rs m9,9984,725 211.6%   
Net working cap to sales %-7.537.0 -20.3%  
Current ratio x0.93.1 30.2%  
Inventory Days Days4651 90.1%  
Debtors Days Days6020 306.5%  
Net fixed assets Rs m10,1241,113 909.7%   
Share capital Rs m206213 96.8%   
"Free" reserves Rs m5,58210,808 51.7%   
Net worth Rs m7,73411,076 69.8%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88216,241 140.9%  
Interest coverage x-0.3497.0 -0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.6 27.2%   
Return on assets %11.816.0 73.3%  
Return on equity %-0.823.4 -3.6%  
Return on capital %22.336.3 61.4%  
Exports to sales %3.00.6 494.3%   
Imports to sales %0.412.6 3.4%   
Exports (fob) Rs m307162 189.7%   
Imports (cif) Rs m433,322 1.3%   
Fx inflow Rs m307268 114.4%   
Fx outflow Rs m1253,927 3.2%   
Net fx Rs m181-3,659 -5.0%   
CASH FLOW
From Operations Rs m11,7542,514 467.5%  
From Investments Rs m-561-800 70.1%  
From Financial Activity Rs m-6,762-803 842.2%  
Net Cashflow Rs m4,432912 486.0%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 16.8 0.1 16,800.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 17.1 211.1%  
Shareholders   16,479 18,270 90.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   TORRENT PHARMA  NATCO PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Steady Despite North Korea Threat(RoundUp)

Global financial markets ended the week on a flat note despite North Korea once again threatening to test a hydrogen bomb in the Pacific Ocean.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Rule-Based Investing Can Make A Lot of Money(The 5 Minute Wrapup)

Sep 16, 2017

We take a glimpse of Equitymaster's results from rule based investing.

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - LUPIN LTD COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS